GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Shiller PE Ratio

Vivozon Pharmaceutical Co (XKRX:082800) Shiller PE Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivozon Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vivozon Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Vivozon Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivozon Pharmaceutical Co Shiller PE Ratio Chart

Vivozon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vivozon Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vivozon Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Vivozon Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivozon Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivozon Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vivozon Pharmaceutical Co's Shiller PE Ratio falls into.



Vivozon Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vivozon Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Vivozon Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-42/118.8477*118.8477
=-42.000

Current CPI (Mar. 2024) = 118.8477.

Vivozon Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -65.000 99.353 -77.754
201409 -215.000 99.608 -256.528
201412 70.000 99.098 83.951
201503 -335.000 99.720 -399.258
201506 -305.000 100.050 -362.304
201509 -85.000 100.110 -100.910
201512 -560.000 100.220 -664.086
201603 10.000 100.560 11.819
201606 -225.000 100.790 -265.311
201609 -30.000 101.460 -35.141
201612 15.000 101.560 17.553
201703 -15.000 102.850 -17.333
201706 -190.000 102.610 -220.067
201709 -135.000 103.490 -155.034
201712 -450.000 102.990 -519.288
201803 -120.000 104.100 -137.000
201806 -310.000 104.130 -353.815
201809 -755.000 105.650 -849.314
201812 104.452 104.350 118.964
201903 -45.000 104.490 -51.183
201906 -270.000 104.880 -305.958
201909 40.000 105.200 45.189
201912 -996.636 105.120 -1,126.787
202003 -430.000 105.540 -484.219
202006 40.000 104.870 45.331
202009 -80.000 106.200 -89.527
202012 -1,215.000 105.765 -1,365.285
202103 -205.000 107.357 -226.941
202106 -35.000 107.579 -38.666
202109 -250.000 108.759 -273.190
202112 -1,640.000 109.676 -1,777.139
202203 -255.000 111.806 -271.061
202206 -170.000 114.083 -177.100
202209 -130.000 114.831 -134.547
202212 -380.216 115.200 -392.255
202303 -455.000 116.550 -463.972
202306 -5.000 117.140 -5.073
202309 5.000 119.111 4.989
202312 -30.000 118.848 -30.000
202403 -42.000 118.848 -42.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vivozon Pharmaceutical Co  (XKRX:082800) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vivozon Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Vivozon Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivozon Pharmaceutical Co (XKRX:082800) Business Description

Traded in Other Exchanges
N/A
Address
Yongin Techno Valley, 9th and 10th Floor, Building D, Guseong-ro 357, Giheung-gu, Gyeonggi-do, Yongin-si, KOR
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.

Vivozon Pharmaceutical Co (XKRX:082800) Headlines

No Headlines